Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab

Hiraga Junji; Tomita Akihiro; Suzuki Naruko; Takagi Yusuke; Narita Michihiko; Kagami Yoshitoyo

首页> 外文期刊>Annals of hematology >Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab

【24h】

Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab

机译：用RITuximab后，用氮杂氨酸在CD20阴性转化弥漫性大B细胞淋巴瘤中处理后CD20蛋白表达和Rituximab敏感性的敏感性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of hematology》 |2018年第11期|共3页
作者
Hiraga Junji; Tomita Akihiro; Suzuki Naruko; Takagi Yusuke; Narita Michihiko; Kagami Yoshitoyo;
展开▼
作者单位

Toyota Kosei Hosp Dept Hematol 500-1 Ibobara Josui Cho Toyota 4700396 Japan;

Fujita Hlth Univ Sch Med Dept Hematol Toyoake Aichi Japan;

Toyota Kosei Hosp Dept Hematol 500-1 Ibobara Josui Cho Toyota 4700396 Japan;

Toyota Kosei Hosp Dept Hematol 500-1 Ibobara Josui Cho Toyota 4700396 Japan;

Toyota Kosei Hosp Dept Pathol Toyota Japan;

Toyota Kosei Hosp Dept Hematol 500-1 Ibobara Josui Cho Toyota 4700396 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
入库时间 2022-08-20 01:03:13

相似文献

外文文献
中文文献
专利

1. Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab [J] . Hiraga Junji, Tomita Akihiro, Suzuki Naruko, Annals of hematology . 2018,第11期

机译：用RITuximab后，用氮杂氨酸在CD20阴性转化弥漫性大B细胞淋巴瘤中处理后CD20蛋白表达和Rituximab敏感性的敏感性
2. Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy [J] . Iguchi T, Miyazawa K, Okabe S, 臨床血液 . 2004,第10期

机译：抗CD20单克隆抗体（利妥昔单抗）治疗后，弥漫性大B细胞淋巴瘤立即复发至CD20阴性的多发性皮肤肿瘤
3. The relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy [J] . Iguchi T, Miyazawa K, Okabe S, 臨床血液 . 2004,第10期

机译：抗CD20单克隆抗体（RITuximab）治疗后立即将衍射大B细胞淋巴瘤的复发大量淋巴瘤至CD20阴性多皮肤肿瘤
4. Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma [C] . Bohua Li, Hao Wang, Yajun Guo, International conference of molecular simulations and applied informatics technologies . 2012

机译：具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
5. Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin's lymphoma (B-NHL) [D] . Tsai, Ping-Chiao 2012

机译：CD20在利妥昔单抗耐药细胞系（RRCL）和B细胞非霍奇金淋巴瘤（B-NHL）中的调节
6. Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group [O] . Naoki Wada, Masaharu Kohara, Hiroyasu Ogawa, 2009

机译：抗CD20单克隆抗体利妥昔单抗治疗的弥漫性大B细胞淋巴瘤中CD20表达的变化：大阪淋巴瘤研究组的研究
7. Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group [O] . Wada, Naoki, Kohara, Masaharu, Ogawa, Hiroyasu, 2009

机译：抗CD20单克隆抗体利妥昔单抗治疗的弥漫性大B细胞淋巴瘤中CD20表达的变化：大阪淋巴瘤研究组的研究

Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab

著录项

相似文献

相关主题

期刊订阅